🔗 Permalink

Assignee profile:

ALPINE IMMUNE SCIENCES, INC.

City:

Seattle, Washington

Country:

United States

Published Applications:

Last publication date:

2025-07-31

Patent Grants:

Last grant date:

2025-05-20

Top Inventors for applications by ALPINE IMMUNE SCIENCES, INC.

These are the the leading inventors for applications assigned to ALPINE IMMUNE SCIENCES, INC.:

Ryan SWANSON 37 Seattle, WA United States
Michael KORNACKER 27 Seattle, WA United States
Daniel William DEMONTE 22 Seattle, WA United States
Mark F. Maurer 14 Seattle, WA United States

Joseph L. KUIJPER 11 Seattle, WA United States
Dan ARDOUREL 10 Seattle, WA United States
Joseph L. Kuijper 10 Kenmore, WA United States
Stanford L. PENG 9 Seattle, WA United States

Lawrence EVANS 8 Seattle, WA United States
Stacey DILLON 8 Seattle, WA United States
Mark RIXON 7 Seattle, WA United States
Lawrence EVANS 5 Seattle, CA United States

Jing YANG 3 Seattle, WA United States
Dan ARDOUREL 2 Woodinville, WA United States
Jan HILLSON 1 Seattle, WA United States
Kristine M. SWIDEREK 1 Seattle, WA United States

Joseph L. KUJIPER 1 Kenmore, WA United States
Stanford Peng 1 Seattle, WA United States
Steven Dennis LEVIN 1 Seattle, WA United States

Recent patent applications by ALPINE IMMUNE SCIENCES, INC.

ALPINE IMMUNE SCIENCES, INC. based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-07-31

US20250243260A1

Chemistry; metallurgy

IMMUNOMODULATORY PROTEINS OF VARIANT CD80 POLYPEPTIDES, CELL THERAPIES AND RELATED METHODS AND USES

#2 | 2025-01-16

US20250019413A1

Chemistry; metallurgy

APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF

#3 | 2025-01-16

US20250019412A1

Chemistry; metallurgy

APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF

#4 | 2024-12-12

US20240409660A1

Chemistry; metallurgy

ICOS LIGAND VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#5 | 2024-12-05 ✅ Patent 12,304,943 granted on 2025-05-20

US20240400643A1

Chemistry; metallurgy

April and BAFF inhibitory immunomodulatory proteins and methods of use thereof

#6 | 2024-10-31

US20240360197A1

Chemistry; metallurgy

PD-1 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#7 | 2024-08-22

US20240279310A1

Chemistry; metallurgy

METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEIN

#8 | 2024-07-04 ✅ Patent 12,612,447 granted on 2026-04-28

US20240218045A1

Chemistry; metallurgy

APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF

#9 | 2024-05-16 ✅ Patent 12,358,969 granted on 2025-07-15

US20240158463A1

Chemistry; metallurgy

CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#10 | 2024-01-04

US20240002466A1

Chemistry; metallurgy

CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#11 | 2023-11-30 ✅ Patent 12,624,087 granted on 2026-05-12

US20230381229A1

Human necessities

CD155 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#12 | 2023-08-10 ✅ Patent 12,612,446 granted on 2026-04-28

US20230250152A1

Chemistry; metallurgy

CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#13 | 2023-08-03

US20230241168A1

Human necessities

APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS WITH AND WITHOUT A T CELL INHIBITORY PROTEIN AND METHODS OF USE THEREOF

#14 | 2023-07-27

US20230235012A1

Chemistry; metallurgy

VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS

#15 | 2023-07-13

US20230220039A1

Chemistry; metallurgy

PD-L1 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#16 | 2023-05-04

US20230136723A1

Chemistry; metallurgy

CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#17 | 2023-03-30 ✅ Patent 12,297,253 granted on 2025-05-13

US20230101432A1

Chemistry; metallurgy

Multi-domain immunomodulatory proteins and methods of use thereof

#18 | 2022-11-24 ✅ Patent 12,552,853 granted on 2026-02-17

US20220372106A1

Chemistry; metallurgy

CD86 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#19 | 2022-08-04 ✅ Patent 12,486,312 granted on 2025-12-02

US20220242930A1

Chemistry; metallurgy

IMMUNOMODULATORY PROTEINS WITH TUNABLE AFFINITIES

#20 | 2022-07-14

US20220218785A1

Human necessities

METHODS AND USES OF VARIANT ICOS LIGAND (ICOSL) FUSION PROTEINS

#21 | 2022-06-09

US20220177587A1

Chemistry; metallurgy

METHODS AND USES OF VARIANT CD80 FUSION PROTEINS AND RELATED CONSTRUCTS

#22 | 2022-05-26 ✅ Patent 11,479,609 granted on 2022-10-25

US20220162319A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#23 | 2022-05-19 ✅ Patent 11,498,967 granted on 2022-11-15

US20220153846A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#24 | 2022-04-14 ✅ Patent 11,613,566 granted on 2023-03-28

US20220112265A1

Chemistry; metallurgy

Variant ICOS ligand immunomodulatory proteins and related compositions and methods

#25 | 2021-12-16 ✅ Patent 12,202,882 granted on 2025-01-21

US20210388054A1

Chemistry; metallurgy

APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof

#26 | 2021-11-25 ✅ Patent 11,274,140 granted on 2022-03-15

US20210363223A1

Chemistry; metallurgy

APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof

#27 | 2021-11-25 ✅ Patent 12,065,476 granted on 2024-08-20

US20210363219A1

Chemistry; metallurgy

PD-1 variant immunomodulatory proteins and uses thereof

#28 | 2021-11-11 ✅ Patent 11,359,022 granted on 2022-06-14

US20210347897A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#29 | 2021-08-19 ✅ Patent 11,834,490 granted on 2023-12-05

US20210253668A1

Chemistry; metallurgy

CD112 variant immunomodulatory proteins and uses thereof

#30 | 2021-06-24 ✅ Patent 12,110,339 granted on 2024-10-08

US20210188995A1

Chemistry; metallurgy

ICOS ligand variant immunomodulatory proteins and uses thereof

#31 | 2021-06-24 ✅ Patent 11,117,950 granted on 2021-09-14

US20210188942A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#32 | 2021-06-10 ✅ Patent 11,117,949 granted on 2021-09-14

US20210171603A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#33 | 2021-06-03 ✅ Patent 11,230,588 granted on 2022-01-25

US20210163571A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#34 | 2021-05-27 ✅ Patent 11,096,988 granted on 2021-08-24

US20210155669A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#35 | 2021-05-27 ✅ Patent 11,117,948 granted on 2021-09-14

US20210155668A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#36 | 2021-05-06 ✅ Patent 11,732,022 granted on 2023-08-22

US20210130437A1

Chemistry; metallurgy

PD-L2 variant immunomodulatory proteins and uses thereof

#37 | 2021-05-06 ✅ Patent 11,639,375 granted on 2023-05-02

US20210130436A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#38 | 2020-10-01 ✅ Patent 11,753,458 granted on 2023-09-12

US20200308249A1

Chemistry; metallurgy

CTLA-4 variant immunomodulatory proteins and uses thereof

#39 | 2020-09-10

US20200283500A1

Chemistry; metallurgy

VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS

#40 | 2020-02-06

US20200040059A1

Chemistry; metallurgy

SECRETABLE VARIANT IMMUNOMODULATORY PROTEINS AND ENGINEERED CELL THERAPY

#41 | 2019-06-13 ✅ Patent 11,471,488 granted on 2022-10-18

US20190175654A1

Human necessities

CD155 variant immunomodulatory proteins and uses thereof

#42 | 2019-05-09 ✅ Patent 11,078,282 granted on 2021-08-03

US20190135922A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#43 | 2018-09-13

US20180256644A1

Human necessities

TUNABLE VARIANT IMMUNOGLOBULIN SUPERFAMILY DOMAINS AND ENGINEERED CELL THERAPY

#44 | 2018-08-30 ✅ Patent 11,319,359 granted on 2022-05-03

US20180244749A1

Chemistry; metallurgy

Immunomodulatory proteins with tunable affinities

#45 | 2017-11-09 ✅ Patent 10,882,914 granted on 2021-01-05

US20170320959A1

Chemistry; metallurgy

ICOS ligand variant immunomodulatory proteins and uses thereof

Also check out Alpine Immune Sciences, Inc.'s (Seattle, United States) applicant profile with 39 patent applications submitted.

AssigneeID:

128744 ⎘